100% Portuguese drug for rheumatoid arthritis to be tested on patients
The research is being promoted by the biotechnology company Solfarcos, and its partners are Bluepharma and BlueClinical, leading companies in the health sector.
The future 100% Portuguese drug for treating rheumatoid arthrit